Soleno Therapeutics宣布DCCR(二氮嗪胆碱控释片)治疗Prader-Wii综合征(PWS小胖威利综合征)获美国FDA突破性疗法认定 Gallery Soleno Therapeutics宣布DCCR(二氮嗪胆碱控释片)治疗Prader-Wii综合征(PWS小胖威利综合征)获美国FDA突破性疗法认定 美国投资项目 Soleno Therapeutics宣布DCCR(二氮嗪胆碱控释片)治疗Prader-Wii综合征(PWS小胖威利综合征)获美国FDA突破性疗法认定 2024-04-29 05:20:38 04月 29日, 2024 | 阅读更多
RayzeBio被BMS 41亿美元收购,用于扩充差异化平台和管线 Gallery RayzeBio被BMS 41亿美元收购,用于扩充差异化平台和管线 美国投资项目 RayzeBio被BMS 41亿美元收购,用于扩充差异化平台和管线 2024-01-03 16:56:53 01月 03日, 2024 | 阅读更多
Vivo Capital’s Portfolio Company IO Biotech Announces an IPO Gallery Vivo Capital’s Portfolio Company IO Biotech Announces an IPO 美国投资项目 Vivo Capital’s Portfolio Company IO Biotech Announces an IPO 2022-03-09 14:24:30 03月 09日, 2022 | 阅读更多
Vivo Capital’s Portfolio Company Aadi BioSceince announced a FDA approval of FYARRO for Patients with Locally Advanced Unresectable or Metastatic Malignant Perivascular Epithelioid Cell Tumor (PEComa) Gallery Vivo Capital’s Portfolio Company Aadi BioSceince announced a FDA approval of FYARRO for Patients with Locally Advanced Unresectable or Metastatic Malignant Perivascular Epithelioid Cell Tumor (PEComa) 美国投资项目 Vivo Capital’s Portfolio Company Aadi BioSceince announced a FDA approval of FYARRO for Patients with Locally Advanced Unresectable or Metastatic Malignant Perivascular Epithelioid Cell Tumor (PEComa) 2022-03-09 14:23:29 03月 09日, 2022 | 阅读更多
Vivo Capital, Co-Leads a $75m Series A Round of Financing in Ablaze Pharmaceuticals Gallery Vivo Capital, Co-Leads a $75m Series A Round of Financing in Ablaze Pharmaceuticals 美国投资项目 Vivo Capital, Co-Leads a $75m Series A Round of Financing in Ablaze Pharmaceuticals 2022-03-09 14:22:32 03月 09日, 2022 | 阅读更多
Vivo Capital, Leads a $200m Series A Round of Financing in Avistone Pharmaceuticals Gallery Vivo Capital, Leads a $200m Series A Round of Financing in Avistone Pharmaceuticals 美国投资项目 Vivo Capital, Leads a $200m Series A Round of Financing in Avistone Pharmaceuticals 2022-03-09 14:21:40 03月 09日, 2022 | 阅读更多
Legend Biotech Announces FDA Approval of CARVYKTI Gallery Legend Biotech Announces FDA Approval of CARVYKTI 美国投资项目 Legend Biotech Announces FDA Approval of CARVYKTI 2022-03-09 09:29:48 03月 09日, 2022 | 阅读更多